Immediate U.S. launch planned for Farxiga®-equivalent diabetes drug; opportunity pegged at $10.2 billion in annual market size
Immediate U.S. launch planned for dapagliflozin-metformin ER tablets; addressable market estimated at $514 millionannually
Interchangeable biosimilars to Prolia and Xgeva target osteoporosis and cancer-related bone complications in a $5 billion U.S. market
Immediate opportunity in the $10.2 billion U.S. market as the diabetes therapy will be manufactured at Zydus’ SEZ Ahmedabad facility
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
Phase I to supply clean energy to five facilities, with long-term plans to power 19 hospitals through a 30 MW renewable network
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
The open-label trial involved 105 adults with schizophrenia who were on a stable dose of an oral atypical antipsychotic for at least six weeks
Subscribe To Our Newsletter & Stay Updated
